Myung In Pharmaceutical LTD. (KRX:317450)
South Korea flag South Korea · Delayed Price · Currency is KRW
72,600
-1,100 (-1.49%)
At close: Dec 5, 2025

KRX:317450 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Debt / Equity Ratio
0.000.010.010.010.020.02
Upgrade
Debt / EBITDA Ratio
0.020.030.040.060.070.09
Upgrade
Debt / FCF Ratio
0.030.040.050.090.090.15
Upgrade
Asset Turnover
-0.490.490.500.520.52
Upgrade
Inventory Turnover
-1.731.701.741.561.78
Upgrade
Quick Ratio
12.757.286.375.764.523.53
Upgrade
Current Ratio
14.278.657.857.155.714.73
Upgrade
Return on Equity (ROE)
-13.68%16.63%14.36%16.91%14.37%
Upgrade
Return on Assets (ROA)
-10.51%10.52%10.53%11.41%11.17%
Upgrade
Return on Capital (ROIC)
-11.47%11.55%11.70%12.90%12.66%
Upgrade
Return on Capital Employed (ROCE)
11.70%17.30%17.30%17.40%19.00%18.80%
Upgrade
Payout Ratio
15.52%8.15%30.06%19.50%23.43%43.10%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.